Diabetes complications

Diabetic complications in women with type 2 diabetes and polycystic ovary syndrome

Eur J EndocrinolPublished Nationwide register-based cohort study

Main finding · Diabetic complicationsResult — go to the resultAdjusted hazard ratio 0.70 95% CI 0.60–0.82

Authors' conclusion

The findings of the present register study suggest that PCOS does not seem to increase the risk of diabetic complications. However, studies with longer follow-up and clinical data, such as body mass index, are needed to verify this.

Study context

Population
Women with T2D in the nationwide Diabetes in Finland database, 1996–2017
Participants
1,288 vs 177,555
Exposure
Polycystic ovary syndrome (PCOS) + T2D vs T2D without PCOS
  • PCOSn = 1,288
  • Controlsn = 177,555reference
Outcome
Diabetic complications: composite of retinopathy, neuropathy, nephropathy, cardiovascular, cerebrovascular or foot complications, and all-cause death
Follow-up
1996-2017
Methodological detailsCox regression with PCOS as time-dependent variable, matched sub-analysis
  • Cox regression with PCOS as time-dependent variable
  • Matched sub-analysis

Main finding

Diabetic complications

Adjusted hazard ratio

0.70

95% CI 0.60–0.82

PCOSvs Controls
aHR 0.70 (95% CI 0.60–0.82)

As reported in the abstract

Observational data: associations, not effects.

Further findings

Age at T2D diagnosis

OutcomePCOSControls
20-year cumulative incidence of diabetic complication after T2D diagnosis (unadjusted) · matched sub-analysis35%— not stated in the abstract

— not stated in the abstract

  • 20-year cumulative incidence of diabetic complication after T2D diagnosis (unadjusted): Matched controls 48%

Age at T2D diagnosis

Significantly lower with PCOS

Original publication

Diabetic complications in women with type 2 diabetes and polycystic ovary syndrome. Eur J Endocrinol. Published 21 February 2025. doi:10.1093/ejendo/lvaf026

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.